// App-Quantinova.ai

2577 : Phase I study of pazopanib (PAZ) in combination with abexinostat (ABX) in patients (Pts) with metastatic solid tumors.

Researchers

Presenter

  • Rahul Raj Aggarwal

Principal Investigators

  • Jennifer A. Grabowsky

  • Thierry Marie Jahan

  • Alain Patrick Algazi

  • Terence W. Friedlander

  • Thach-Giao Truong

  • Saloni Mathur

  • Pamela N. Munster

  • Anne Reinert

  • Scott Thomas

  • Paromita Raha

Medical Centers

  • University of California, San Francisco, San Francisco, CA

  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Abexinostat

  • Pazopanib

Outcome

  • Unknown

Study Design

  • pharmacokinetics

Phase

  • I

Study Id's

  • NCT01543763

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved